ACE2 and COVID-19: A study by Daniels et al.36 indicated statin use prior to hospital admission reduced the risk of severe COVID-19, while other studies suggested an elevated risk due to modulation of ACE2 expression and immune responses.37,38 Our findings of an association between THZs, statins, and increased COVID-19 risk underscore the need for further investigation.